spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cerebral 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 3 Sep 2025
Terumo Neuro Unveils New SOFIA(TM) Flow 88 Neurovascular Aspiration Catheter Data from EMEA Demonstrating Strong Performance
Devices Interventional Neurology
 HSMN NewsFeed - 3 Sep 2025
Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care
Devices Interventional Neurology
 HSMN NewsFeed - 21 Apr 2025
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
Devices Monitoring Product Launch
 HSMN NewsFeed - 19 Mar 2025
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
Devices Interventional Neurology
 HSMN NewsFeed - 27 Dec 2024
NAVIGANTIS VASCO(TM) Robotic Platform Used with First Patients Enrolled in Neurovascular Study
Devices Interventional Neurology
 HSMN NewsFeed - 20 Sep 2024
Stryker Completes Acquisition of NICO Corporation, Expanding Minimally Invasive Solutions for Brain Tumor Removal and Stroke Care
Devices Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jul 2024
CereVasc Announces Appointments of New Directors
Devices Neurosurgery Personnel
 HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 13 May 2024
CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 8 May 2024
Alcyone Therapeutics Announces Appointment of Dr. Norbert Riedel as Chairman of the Board and Dr. Kathrin Meyer as Chief Scientific Officer and Head of Research & Development
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 3 May 2024
Leading Academic Neurosurgeons Describe New NICO Myriad SPECTRA(TM) System as a 'Game-Changing Advancement' in Surgical Removal of High-Grade Glioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 12 Mar 2024
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner(R) Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2023
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Devices Neurosurgery Personnel
 HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Diagnostics
 HSMN NewsFeed - 27 Jan 2023
Infinity Neuro Receives CE Mark Approval for Their First Device to Treat Stroke
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 23 Aug 2022
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 9 Aug 2022
CereVasc Announces FDA Approval of Second IDE Study of the eShunt(R) System
Devices Neurosurgery Interventional FDA
 HSMN NewsFeed - 6 Jul 2022
ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date
Devices Neurosurgery
 HSMN NewsFeed - 18 Mar 2022
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA
 HSMN NewsFeed - 8 Feb 2022
CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt(R) System for Patients with Normal Pressure Hydrocephalus
Devices Interventional Neurosurgery FDA
 HSMN NewsFeed - 7 Jan 2022
NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting
Devices Monitoring Cardiology
 HSMN NewsFeed - 14 Dec 2021
Medtronic INVOS(TM) 7100 Cerebral/Somatic Oximetry System receives 510(k) clearance for pediatric indications
Devices Monitoring FDA
 HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2021
SpinTech Receives FDA 510(k) Clearance for STAGE Technology
Devices Radiology Neurology FDA
 HSMN NewsFeed - 21 Apr 2021
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
Devices Interventional FDA
 HSMN NewsFeed - 1 Feb 2021
New Scientific Publications Show Diadem's Blood-Based AlzoSure(R) Biomarker Test Can Predict Which Patients Will Progress to Alzheimer's Disease Years Before Symptoms Occur
Diagnostics Neurology
 HSMN NewsFeed - 14 Jan 2021
Nonin Medical Announces New Full Board of Directors
Devices Monitoring Personnel
 HSMN NewsFeed - 12 Jan 2021
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
Devices Neurosurgery FDA
 HSMN NewsFeed - 23 Nov 2020
Rapid Medical Expands Comaneci(TM) CE Mark Indication to Include Vasospasm Treatment
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 17 Nov 2020
Boston Scientific Announces LOTUS Edge(TM) Aortic Valve System Voluntary Recall and Product Discontinuation
Devices Interventional Cardiology Product Recall
 HSMN NewsFeed - 8 Oct 2020
First Patients Treated with Galaxy Medical's Centauri(TM) Pulsed Electric Field Cardiac Ablation System
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Sep 2020
Boston Scientific Launches ACURATE neo2(TM) Aortic Valve System in Europe
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Jun 2020
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2020
U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa(R) for Third Year
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 29 Apr 2020
Cerus Endovascular Receives CE Mark Approval for its 021 Contour Neurovascular System(TM)
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 22 Apr 2020
Cerus Endovascular Receives CE Mark Approvals for its Neqstent(TM) Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 7 Apr 2020
Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid Services, Effective July 1, 2020
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 30 Mar 2020
MIVI Neuroscience Promotes Bob Colloton to CEO and Appoints Robert Stern to Board of Directors
Devices Interventional Radiology Personnel
 HSMN NewsFeed - 25 Mar 2020
University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 17 Mar 2020
Artio Medical Announces Interim Study Results Highlighting Aneurysm Occlusion Device at Neurovascular Conference
Devices Neurology Interventional
 HSMN NewsFeed - 10 Mar 2020
TriGUARD 3(TM) Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Mar 2020
New Data Demonstrates Andexxa(R) Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2020
Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
Devices Interventional Neurology Venture Capital FDA
 HSMN NewsFeed - 18 Feb 2020
Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System(TM), Designed to Treat Intracranial Aneurysms
Devices Interventional Radiology Regulatory
 HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Oct 2019
Perflow Medical Receives CE Mark Approval of Novel Cascade(TM) Agile
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 17 Oct 2019
Teijin and NeuroSigma Enter into Exclusive License Agreement
Devices Neurology Licensing
 HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 1 Aug 2019
Neuronetics(R) Announces First TMS Patient Treated Under New Japan Reimbursement Policy
Devices Neurology Reimbursement
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jul 2019
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator(R) Device for Non-Invasive Treatment of Spasticity
Devices Neurology
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2019
Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
Devices Interventional FDA
 HSMN NewsFeed - 16 Apr 2019
Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Mar 2019
Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2019
Edwards Lifesciences Enters Into Agreement To Acquire CASMED
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 26 Dec 2018
Venus Medtech Completes Merger with Keystone Heart, Ltd.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2018
Contego Medical Receives 510(k) Clearance for the Vanguard IEP Peripheral Angioplasty System with Integrated Embolic Protection
Devices Interventional FDA
 HSMN NewsFeed - 27 Nov 2018
Cerus Endovascular Expands Intellectual Property Portfolio
Devices Interventional Neurology
 HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2018
FDA Clears Augmented Reality Visualization Solution GLOW800
Devices Neurosurgery FDA
 HSMN NewsFeed - 17 Aug 2018
Eisai And Merck Announce FDA Approval Of LENVIMA(R) (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Aug 2018
Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision
Devices Interventional Acquisitions Reimbursement
 HSMN NewsFeed - 23 Jul 2018
Perflow Medical Announces the First Clinical Use of the Cascade(TM) Dynamic Non-Occlusive Remodeling Net
Devices Interventional Neurology
 HSMN NewsFeed - 20 Jul 2018
Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 28 Jun 2018
Biohaven Expands Rimegepant Development Program to Include New Prevention of Migraine Phase 3 Trial and Highlights Key Late-Breaking Presentations at American Headache Society (AHS) Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2018
Cerus Endovascular Promotes Stephen Griffin, PhD, to President
Devices Interventional Radiology Neurology Personnel
 HSMN NewsFeed - 9 May 2018
Adventus Ventures announces initial financing for several of its medical device portfolio companies
Devices Venture Capital
 HSMN NewsFeed - 8 May 2018
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
Devices Cardiology
 HSMN NewsFeed - 19 Apr 2018
Emboline, Inc. Completes Funding Of Over $10 Million
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Feb 2018
Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 19 Jan 2018
Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jan 2018
GSK receives FDA approval for expanded indication for FLUARIX(R) QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jan 2018
New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
Devices Drug Delivery Neurology
 HSMN NewsFeed - 11 Dec 2017
Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Oct 2017
UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD
Devices Neurology
 HSMN NewsFeed - 12 Oct 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Oct 2017
Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Aug 2017
Leica FL560 achieves First FDA Clearance for cerebrovascular fluorescence with fluorescein
Devices Neurosurgery FDA
 HSMN NewsFeed - 11 Jul 2017
Prometic Announces Positive Long Term Clinical Data on Ryplazym(TM) in Plasminogen Congenital Deficiency and Provides Regulatory Update
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2017
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 10 Apr 2017
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
Devices Neurology Interventional Mergers & Acquisitions
 HSMN NewsFeed - 4 Apr 2017
Synchron Inc. Secures $10 Million in Series A Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 10 Mar 2017
Cadwell Launches Arc Synopsis(TM) Trends and Seizure Detection
Devices Monitoring Neurology Product Launch
 HSMN NewsFeed - 2 Mar 2017
Keystone Heart and Venus Medtech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Nov 2016
Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries
Devices Interventional Venture Capital
 HSMN NewsFeed - 21 Nov 2016
Neural Analytics Announces Commercial Launch of Lucid(TM) M1 Transcranial Doppler Ultrasound System at 9th Annual Society of Vascular and Interventional Neurology Meeting
Devices Monitoring Neurology Product Launch
 HSMN NewsFeed - 21 Nov 2016
GSK Receives FDA Approval for Expanded Indication for Flulaval(R) Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional
 HSMN NewsFeed - 8 Sep 2016
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
Devices Neurology Interventional Product Launch
 HSMN NewsFeed - 3 Aug 2016
Ornim Raises $20 Million in Latest Equity Financing Round
Devices Monitoring Venture Capital
 HSMN NewsFeed - 1 Aug 2016
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport(R) (Abobotulinumtoxin A) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2016
Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 19 May 2016
TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients' Neurological Outcomes in TAVR Procedures
Devices Interventional Cardiology Neurology
 HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jan 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2015
NeuroSigma's Monarch eTNS System Receives CE Mark Approval for ADHD
Devices Neurology Regulatory
 HSMN NewsFeed - 29 Oct 2015
CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business
Devices Monitoring Neurosurgery Acqusitions
 HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 11 Aug 2015
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
Devices Neurology Product Launch
 HSMN NewsFeed - 27 Jul 2015
Lenox Hill Hospital Using New Device to Treat Aneurysms
Devices Interventional
 HSMN NewsFeed - 22 Jul 2015
KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jun 2015
Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy
Devices Neurology Interventional Venture Capital
 HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 5 Nov 2014
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Oct 2014
NeuroSigma Receives Notice of Allowance of U.S. Patent Application
Devices Neurology
 HSMN NewsFeed - 6 Oct 2014
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Aug 2014
Highest level evidence published in Neurosurgery journal indicates better outcomes when using iMRI
Devices Radiology Neurosurgery
 HSMN NewsFeed - 11 Jul 2014
Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 8 Jul 2014
Advances in Trigeminal Nerve Stimulation Featured at European Congress on Epileptology in Stockholm, Sweden
Devices Neurology
 HSMN NewsFeed - 24 Jun 2014
Covidien Announces European Launch of Pipeline(TM) Flex Embolization Device
Devices Neurosurgery Interventional Product Launch
 HSMN NewsFeed - 23 Jun 2014
New Philips NeuroSuite Reveals the Brain's Vascular Network like Never Before
Devices Neurology Interventional Radiology
 HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2014
Leading UCLA Physician Dr. Ian Cook Joins NeuroSigma As Chief Medical Officer and Senior Vice President
Devices Neurology Personnel
 HSMN NewsFeed - 29 May 2014
CASMED and Century Medical Execute Distribution Agreement for FORE-SIGHT(R) Oximeters in Japan
Devices Monitoring Distribution
 HSMN NewsFeed - 21 May 2014
Baxter Provides U.S. Regulatory Update on HyQvia, Its Investigational Subcutaneous Treatment for Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Apr 2014
Covidien Implements Voluntary Recall of its Pipeline(TM) Embolization Device and Alligator(TM) Retrieval Device
Devices Product Recall
 HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 28 Mar 2014
NeuroSigma Expands Its Management Team with Two Former Amgen Finance Executives
Devices Neurology Personnel
 HSMN NewsFeed - 24 Mar 2014
Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Feb 2014
David Hayes, Former Partner at O'Melveny & Myers LLP and Haynes and Boone LLP, Joins NeuroSigma As Chief Administrative Officer, General Counsel and Sr. Vice President
Devices Neurology Personnel
 HSMN NewsFeed - 18 Feb 2014
Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the Sentinel(TM) Cerebral Protection System
Devices Interventional FDA
 HSMN NewsFeed - 13 Feb 2014
Ornim Medical Announces New Study Results Demonstrating the Value of the CerOx(TM) Cerebral Oxygen Monitor in the Treatment of Patients With Severe Traumatic Brain Injury
Devices Monitoring Neurosurgery
 HSMN NewsFeed - 11 Feb 2014
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
Devices Neurology Personnel
 HSMN NewsFeed - 5 Feb 2014
Ipsen announces clinical results of Dysport(R) Next Generation (DNG) and its intent to file the first ready-to-use liquid toxin A in Europe and ROW(1)
Biopharmaceuticals
 HSMN NewsFeed - 27 Jan 2014
Former Allergan Marketing Executive Gregory F. Brooks Joins NeuroSigma As Senior VP and Chief Commercial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 30 Dec 2013
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Devices FDA
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 5 Dec 2013
First U.S. Implants of New Medtronic Deep Brain Stimulation System Advance Ground-Breaking Research Into Brain Activity While Therapy Is Delivered
Devices Neurology Personalized Medicine
 HSMN NewsFeed - 3 Dec 2013
CASMED Places 900th FORE-SIGHT(R) Cerebral Oximeter
Devices Monitoring
 HSMN NewsFeed - 3 Dec 2013
Toshiba’s Innovative MR Applications Improve Diagnostic Accuracy and Patient Safety
Devices Radiology
 HSMN NewsFeed - 2 Dec 2013
Claret Medical Announces Filing Of US Pivotal IDE Application For The Sentinel(TM) Cerebral Protection System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Nov 2013
CASMED Receives China Food and Drug Administration Approval for FORE-SIGHT(R) Cerebral Oximeter
Devices Monitoring Regulatory
 HSMN NewsFeed - 21 Oct 2013
Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
Devices Monitoring Neurosurgery Product Launch
 HSMN NewsFeed - 15 Oct 2013
Pulsar Vascular Receives CE Mark Approval For PulseRider(R)
Devices Interventional Regulatory Product Launch
 HSMN NewsFeed - 7 Oct 2013
Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Sep 2013
Bioness Appoints Todd Cushman as President & CEO
Devices Neurology Personnel
 HSMN NewsFeed - 19 Sep 2013
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 3 Sep 2013
Spectrum Pharmaceuticals Launches Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) and Ships First Commercial Orders
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 30 Aug 2013
Jan Medical Announces Corporate Collaboration With, and Further Investment By, Brainlab
Devices Neurosurgery Monitoring Venture Capital
 HSMN NewsFeed - 26 Aug 2013
Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 16 Aug 2013
Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jul 2013
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
Devices Interventional Neurology
 HSMN NewsFeed - 27 Jun 2013
Medtronic Issues Medical Device Notifications Regarding the SynchroMed(R) Implantable Infusion System
Devices Drug Delivery Product Recall
 HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing
 HSMN NewsFeed - 4 Jun 2013
Edge Therapeutics Raises $18 Million to Advance Clinical Development of Potentially Life-Saving Hospital Products
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 May 2013
Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2013
Integra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual Meeting
Devices Neurosurgery Monitoring Product Launch
 HSMN NewsFeed - 5 Apr 2013
Terumo Cardiovascular Systems Announces U.S. Distribution Agreement with Nonin Medical for Nonin's EQUANOX(TM) 7600 Regional Oximetry System
Devices Monitoring Distribution
 HSMN NewsFeed - 27 Feb 2013
Surgical Theater, LLC(TM) Receives FDA Clearance for Surgery Rehearsal Platform(TM)
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 27 Feb 2013
Claret Medical, Inc. Announces CE Mark Approval of Montage 2(TM) and Live Case Debut During JIM 2013
Devices Interventional Regulatory
 HSMN NewsFeed - 8 Feb 2013
Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Feb 2013
CASMED Announces Recent Publication of Study Using FORE-SIGHT Cerebral Tissue Oximetry in the Post-Surgical ICU
Devices Monitoring Neurology Surgery
 HSMN NewsFeed - 24 Jan 2013
Acorda Therapeutics Announces Department of Defense Contract to Support Study of AC105 in Acute Spinal Cord Injury
Biopharmaceuticals Neurology Neurosurgery
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 10 Jan 2013
Alere Executes License Agreement with Miraculins for Preeclampsia Technology
Diagnostics Licensing
 HSMN NewsFeed - 21 Dec 2012
Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2012
CAS Medical Systems Names Dr. John Gamelin as Vice President of Research & Development
Devices Monitoring Neurology Personnel
 HSMN NewsFeed - 11 Dec 2012
Sequent Medical, Inc. Launches VIA Microcatheter
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Oct 2012
Acorda Therapeutics Names Jane Wasman President, International
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2012
Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2012
Pfizer Receives EU Marketing Authorization for INLYTA(R) (Axitinib)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2012
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2012
Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jul 2012
Blockade Medical(TM) Receives CE Mark for the Barricade Coil System(TM)
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 13 Jul 2012
ProTron's Cerebral Stethoscope Offers Breakthrough for Early Detection of Aneurysms
Devices
 HSMN NewsFeed - 2 Jul 2012
NeuroSigma Receives Global Quality Control Certification
Devices Regulatory
 HSMN NewsFeed - 28 Jun 2012
CAS Medical Systems Announces Publication of Study Using FORE-SIGHT(R) to Improve Identification of Children With Sickle Cell Disease at Highest Risk for Neurologic Injury in Pediatric Blood and Cancer Journal
Devices Monitoring
 HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Jun 2012
Neuronetics, Inc. Receives CE Mark Approval for NeuroStar TMS Therapy
Devices Neurology Regulatory
 HSMN NewsFeed - 16 May 2012
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
Devices Interventional Neurology Acquisitions
 HSMN NewsFeed - 14 May 2012
Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System
Devices Neurology FDA
 HSMN NewsFeed - 3 May 2012
Covidien and GE Healthcare Form Five-Year Collaboration
Devices Monitoring
 HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Feb 2012
CASMED's FORE-SIGHT(R) Absolute Tissue Oximeter Gains FDA Clearance for Use on Neonatal Abdomen
Devices Monitoring FDA
 HSMN NewsFeed - 27 Jan 2012
U.S. Food And Drug Administration Approves Pfizer’s INLYTA(R) (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jan 2012
European Launch Of Penumbra Separator(TM) 3D Announced At The Working Group In Interventional Neuroradiology (WIN) Seminar
Devices Interventional Radiology Neurology
 HSMN NewsFeed - 6 Dec 2011
Spectros Corporation Signs Distribution Agreements in Middle East
Devices Monitoring Distribution
 HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 9 Nov 2011
Cerebral Stethoscope Offers New Tool for Early Detection of Aneurysms
Devices
 HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2011
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Devices Surgery Monitoring
 HSMN NewsFeed - 26 Aug 2011
Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Aug 2011
NeuroLogica Corporation Receives CE Mark for Its Portable, High-Resolution SPECT Camera, the inSPira HD(TM)
Devices Radiology Neurology Regulatory
 HSMN NewsFeed - 26 Jul 2011
Initiation of Penumbra, Inc.’s THERAPY Trial Announced at the Society of NeuroInterventional Surgery’s 8th Annual Meeting in Colorado Springs, CO
Devices Neurology Interventional
 HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jul 2011
NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
Devices Interventional Licensing
 HSMN NewsFeed - 8 Jul 2011
Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed(R) II Implantable Drug Infusion Pumps
Devices Drug Delivery
 HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 14 Jun 2011
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
Devices Neurology
 HSMN NewsFeed - 13 Jun 2011
Spectros Corporation Introduces Continuum(R), a Broadband Infrared Sensor for Brain and Gut Oximetry
Devices Monitoring
 HSMN NewsFeed - 31 May 2011
Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil(R) Embolic System for Treatment of Cerebral Aneurysms
Devices Interventional
 HSMN NewsFeed - 10 May 2011
First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
Devices Oncology Neurosurgery
 HSMN NewsFeed - 28 Apr 2011
Straub Medical AG receives class-III CE-mark-approval for Rotarex(R)S and Aspirex(R)S endovascular catheter families
Devices Interventional Regulatory
 HSMN NewsFeed - 25 Apr 2011
NeuroSigma Provides Update on Trigeminal Nerve Stimulation (TNS) - the USB Port to the Brain
Devices Neurology
 HSMN NewsFeed - 28 Mar 2011
Toshiba Announces Upgrades to Its Infinix-i Cardiovascular X-ray Systems
Devices Radiology
 HSMN NewsFeed - 28 Feb 2011
Western Medical Center Santa Ana Installs Toshiba’s Vascular X-Ray System to Perform Advanced Diagnostic and Interventional Procedures
Devices Radiology
 HSMN NewsFeed - 10 Jan 2011
CASMED Announces Key Addition to Executive Management Team
Devices Monitoring Personnel
 HSMN NewsFeed - 4 Jan 2011
Sera Prognostics Closes $1.4 Million Series A-1 Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 22 Dec 2010
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Nov 2010
Toshiba’s New Volume Navigation 3D Roadmap Facilitates More Accurate Visualization During Complex Interventions
Devices Radiology
 HSMN NewsFeed - 23 Nov 2010
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen(R) (Baclofen Injection) for the Treatment of Severe Spasticity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Nov 2010
Penumbra, Inc. Enrolls First Patients In PULSE Clinical Trial To Evaluate A Fully Retrievable, Dense Mesh Temporary Stent For Immediate Flow Restoration In Interventional Acute Ischemic Stroke Treatment
Devices Interventional Neurology
 HSMN NewsFeed - 20 Oct 2010
FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Neurology FDA
 HSMN NewsFeed - 5 Oct 2010
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Biopharmaceuticals Neurology Personnel FDA
 HSMN NewsFeed - 21 Sep 2010
Vycor Medical Continues to Build Its Sales and Marketing Infrastructure for Its ViewSite(TM) Neurosurgery Retraction Devices
Devices Neurosurgery Personnel
 HSMN NewsFeed - 26 Aug 2010
NMT Medical Announces Changes in Management and Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 3 Aug 2010
Final Data in International Trial Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil(R) Embolic System for Treatment of Cerebral Aneurysms
Devices Interventional
 HSMN NewsFeed - 29 Jul 2010
Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2010
Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan
Devices Neurology
 HSMN NewsFeed - 12 Jul 2010
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Devices Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Jul 2010
Reverse Medical Corporation Receives CE Mark Approval for the RePort Guide Catheter System for Intracranial Access and Therapeutic Microcatheter Support during Neuro Endovascular Procedures
Devices Interventional Regulatory
 HSMN NewsFeed - 22 Jun 2010
InnerSpace Announces U.S. Market Launch of Hummingbird Neuromonitoring Line
Devices Monitoring Neurosurgery
 HSMN NewsFeed - 17 Jun 2010
Micrus Endovascular Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 16 Jun 2010
SanBio Receives FDA Clearance to Initiate Cell Therapy Clinical Studies for Stroke Recovery
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 16 Jun 2010
Covidien Announces Definitive Agreement to Acquire Somanetics Corporation
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2010
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 May 2010
Somanetics Receives 510(k) Clearance From the FDA to Expand Features on Its Vital Sync Monitor
Devices Monitoring FDA
 HSMN NewsFeed - 19 May 2010
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
Devices Interventional Regulatory
 HSMN NewsFeed - 19 May 2010
NMT Medical Appoints Paul H. Kramer, MD, to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 13 May 2010
Sequent Medical Announces Closing of $15.6 Million Venture Financing
Devices Interventional Venture Capital Personnel
 HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Mar 2010
First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity
Devices Neurology
 HSMN NewsFeed - 9 Mar 2010
Massachusetts Institute of Technology (MIT) to Launch New Brain Research Effort with Acquisition of Elekta MEG Technology
Devices Neurology
 HSMN NewsFeed - 8 Mar 2010
Bioness Appoints New President and CEO
Devices Neurology Personnel
 HSMN NewsFeed - 3 Mar 2010
NMT Medical Appoints John E. Ahern to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 23 Feb 2010
FDA Advisory Committee Recommends Approval Of XIFAXAN(R) (rifaximin) Tablets, 550 Mg for Maintenance of Remission of Hepatic Encephalopathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2010
Novartis Drug Tasigna(R) Receives FDA Priority Review for Newly Diagnosed Patients With Early-Stage Chronic Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2010
CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial
Devices Interventional Neurology
 HSMN NewsFeed - 11 Jan 2010
Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared to Labetalol in Patients with Acute Stoke
Biopharmaceuticals Cardiology Neurology
 HSMN NewsFeed - 7 Jan 2010
Miraculins Announces Partnership With Inverness Medical Innovations to Develop a Diagnostic Test for Preeclampsia
Diagnostics
 HSMN NewsFeed - 5 Jan 2010
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
Devices Interventional
 HSMN NewsFeed - 4 Jan 2010
FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Dec 2009
Novartis Tasigna(R) Trial Shows Superior Results to Gleevec(R) in Patients With Early-Stage Chronic Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2009
VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Dec 2009
CAS Medical Systems, Inc. Announces Publication of Two Studies Demonstrating Use of FORE-SIGHT Absolute Cerebral Oximetry
Devices Monitoring
 HSMN NewsFeed - 2 Dec 2009
Toshiba Showcases Aquilion ONE's Advanced Capabilities in Emergency Department Stroke Setting
Devices Radiology Neurology
 HSMN NewsFeed - 30 Nov 2009
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology
 HSMN NewsFeed - 23 Nov 2009
BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Nov 2009
Covidien Introduces First FDA-Approved Spine Sealant
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 9 Nov 2009
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 23 Oct 2009
Invatec Receives FDA Clearance for Mo.Ma(R) Ultra Proximal Cerebral Protection Device
Devices Interventional FDA
 HSMN NewsFeed - 21 Oct 2009
The Interventional Management of Stroke (IMS) III Trial Protocol Now Includes The Penumbra System, An Aspiration-Based Thrombectomy Device for Interventional Debulking and Removal of Cerebral Clots in Acute Stroke Patients
Devices Interventional Radiology Neurology
 HSMN NewsFeed - 21 Oct 2009
CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2009
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Oct 2009
FDA Approves GARDASIL(R) for Use in Boys and Young Men
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2009
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Sep 2009
Toshiba Introduces Low-Contrast Vascular Imaging
Devices Interventional Cardiology Radiology
 HSMN NewsFeed - 18 Sep 2009
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE(R) (bortezomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Sep 2009
StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
Regenerative Medicine Neurology
 HSMN NewsFeed - 8 Sep 2009
CAS Medical Systems, Inc. Announces Multi-Year Purchase & Sale Agreement With Major U.S. Health Plan Provider
Devices Monitoring Group Purchasing
 HSMN NewsFeed - 2 Sep 2009
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Sep 2009
Leading UK Hospital First to Install FORE-SIGHT Absolute Cerebral Oximetry
Devices Monitoring
 HSMN NewsFeed - 27 Aug 2009
NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 25 Aug 2009
CAS Medical Systems, Inc. Announces FDA 510(k) Clearance Expanding Labeling for FORE-SIGHT Cerebral Oximeter
Devices Monitoring FDA
 HSMN NewsFeed - 24 Aug 2009
Micrus Endovascular Signs Licensing and Development Agreement for Flow Diversion Technology
Devices Neurology Interventional
 HSMN NewsFeed - 14 Aug 2009
Embrella Cardiovascular, Inc. Announces Final Closing of Series B Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 7 Aug 2009
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 Jul 2009
Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
Devices Neurology Interventional
 HSMN NewsFeed - 24 Jun 2009
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Devices Monitoring Cardiology Neurology
 HSMN NewsFeed - 24 Jun 2009
NMT Medical Appoints Chief Operating Officer Richard E. Davis to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 22 Jun 2009
CoAxia, Inc. Announces $21.5M Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 8 Jun 2009
St. Jude Medical Acquires Intellectual Property and Non-Cash Assets of Northstar Neuroscience, Inc.
Devices Neurology Acquisitions
 HSMN NewsFeed - 8 Jun 2009
Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009
Devices Monitoring
 HSMN NewsFeed - 1 Jun 2009
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week (DDW)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 May 2009
Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
Devices Interventional Neurology
 HSMN NewsFeed - 1 May 2009
Integra LifeSciences Will Feature the New LimiTorr Volume Limiting CSF Drainage System At AANS
Devices Neurosurgery
 HSMN NewsFeed - 30 Apr 2009
FDA Approves Dysport(TM) for Therapeutic and Aesthetic Uses
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2009
Long-Term Study with COPAXONE Indicated Protective Effect on Brain Tissue in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Apr 2009
Salix Presents Highly Statistically Significant Results from the Phase III Pivotal Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE)
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2009
Somanetics Announces New FDA 510(K) Clearance
Devices Monitoring FDA
 HSMN NewsFeed - 15 Apr 2009
CAS Medical Systems, Inc. Announces Introduction of FORE-SIGHT Non-Adhesive Small Sensors
Devices Monitoring
 HSMN NewsFeed - 14 Apr 2009
NMT Medical Appoints Frank Martin Permanent President & CEO
Devices Cardiology Personnel
 HSMN NewsFeed - 13 Apr 2009
Arrow International Announces Worldwide Voluntary Recall of Intra Aortic Balloon Pump (IAB) Catheters
Devices Cardiology Product Recall
 HSMN NewsFeed - 9 Apr 2009
NMT Medical Receives PMA Approval for STARFlex as a Ventricular Septal Defect Repair Implant
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Apr 2009
Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 27 Mar 2009
FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I
Devices Neurosurgery Product Recall
 HSMN NewsFeed - 25 Mar 2009
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 20 Mar 2009
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Mar 2009
Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Mar 2009
CytRx's Arimoclomol Demonstrates Statistically Significant Neurorestorative Results in a Preclinical Embolic Stroke Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Feb 2009
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
Devices Interventional Cardiology Neurology Personnel
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 20 Jan 2009
Astro-Med's Grass Technologies Group Receives FDA Clearance to Market Its Neurotrac(R) III Neuromonitoring System
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 18 Dec 2008
StemCells, Inc. Receives FDA Approval To Initiate Clinical Trial Of HuCNS-SC® Cells In A Myelin Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing
 HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA
 HSMN NewsFeed - 2 Oct 2008
Shands at the University of Florida Medical Center Installs the Toshiba Aquilion ONE Dynamic Volume CT
Devices Radiology
 HSMN NewsFeed - 26 Sep 2008
FDA Classifies Medtronic's Notification Related to Improper Connection of Sutureless Intrathecal Catheters as a Class I Recall
Devices Product Recall
 HSMN NewsFeed - 23 Sep 2008
Integra LifeSciences Will Feature the New LimiTorr Volume Limiting CSF Drainage System At Congress of Neurological Surgeons Annual Meeting
Devices Neurosurgery
 HSMN NewsFeed - 23 Sep 2008
Micrus Endovascular Announces Launch of Innovative DeltaPaq Microcoil System
Devices Interventional Neurology
 HSMN NewsFeed - 22 Sep 2008
CAS Medical Systems, Inc. Announces the Sale and Installation of FORE-SIGHT Absolute Cerebral Oximeters At Children's Hospital Boston
Devices Monitoring
 HSMN NewsFeed - 16 Sep 2008
Micrus Endovascular Launches Neuropath Guide Catheter
Devices Neurology Interventional
 HSMN NewsFeed - 15 Sep 2008
CAS Medical Systems, Inc. Announces Addition to Executive Team
Devices Monitoring Personnel
 HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 27 Aug 2008
New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Aug 2008
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 Jul 2008
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 15 Jul 2008
Medtronic Launches First Insertable Cardiac Monitor in Japan
Devices Cardiology Monitoring Regulatory
 HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory
 HSMN NewsFeed - 14 Jul 2008
Micrus Endovascular Receives FDA Approval for Intracranial Stent Clinical Trial
Devices Neurology Interventional FDA
 HSMN NewsFeed - 10 Jul 2008
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
Devices Regulatory Neurology Interventional
 HSMN NewsFeed - 8 Jul 2008
Ascension's 3D Guidance medSAFE(tm) Advancing Earlier Diagnosis of Infantile Cerebral Palsy
Devices Neurology
 HSMN NewsFeed - 23 Jun 2008
Micrus Endovascular Announces CE Mark for PHAROS Vitesse Stent
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2008
Positive Clinical Data Evaluating the Micrus Endovascular Cerecyte Microcoil Published in Peer-Reviewed Journals
Devices Neurosurgery Interventional
 HSMN NewsFeed - 3 Jun 2008
Northstar Neuroscience Announces Presentation of Long-Term Data of Cortical Stimulation for Depression and Stroke Recovery
Devices Neurosurgery
 HSMN NewsFeed - 2 Jun 2008
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2008
Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
Devices Monitoring FDA
 HSMN NewsFeed - 19 May 2008
NMT Medical Announces Settlement of Damages Claims in Patent Infringement Lawsuit with Cardia
Devices Litigation
 HSMN NewsFeed - 13 May 2008
Siemens Introduces Dual Energy Applications for General Imaging
Devices Radiology
 HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery
 HSMN NewsFeed - 25 Apr 2008
Integra LifeSciences Announces Launch of the LimiTorr Volume Limiting CSF Drainage System
Devices Neurosurgery
 HSMN NewsFeed - 23 Apr 2008
Micrus Endovascular and Chemence Medical Products Sign Development Agreement for Liquid Embolic Products
Devices Neurology Interventional
 HSMN NewsFeed - 21 Apr 2008
NeuroLogica Corp. Acquires DDP's Xenon CT Perfusion Technology
Devices Neurology Acquisitions
 HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology
 HSMN NewsFeed - 14 Apr 2008
MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
Devices Cardiology
 HSMN NewsFeed - 10 Apr 2008
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2008
Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
Devices Neurology Interventional
 HSMN NewsFeed - 19 Mar 2008
FDA Classifies Medtronic's Physician Communication Related to Inflammatory Mass Formation from Intrathecal Drug Therapy
Devices Drug Delivery Product Recall FDA
 HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution
 HSMN NewsFeed - 13 Mar 2008
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2008
Siemens Introduces New Dual Energy Applications to SOMATOM Definition
Devices Radiology
 HSMN NewsFeed - 7 Mar 2008
Embrella Cardiovascular, Inc. Hires Carol Burns as Vice President of Product & Business Development
Devices Interventional Personnel
 HSMN NewsFeed - 3 Mar 2008
FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2008
CAS Medical Systems, Inc. Announces FDA 510(k) Clearance for Neonatal FORE-SIGHT Cerebral Oximeter
Devices Monitoring FDA
 HSMN NewsFeed - 26 Feb 2008
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 20 Feb 2008
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Feb 2008
Q Therapeutics Announces Series B Investment
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Feb 2008
Natus Medical to Resume Domestic Shipments of Olympic Cool-Cap
Devices FDA Neurology
 HSMN NewsFeed - 6 Feb 2008
CAS Medical Systems, Inc. Reports Placement of 50th FORE-SIGHT Cerebral Oximeter
Devices Monitoring
 HSMN NewsFeed - 31 Jan 2008
Ipsen: FDA Accepts for Filing a Biologics License Application (BLA) for Dysport(R) in Cervical Dystonia
Biopharmaceuticals
 HSMN NewsFeed - 30 Jan 2008
NMT Medical Announces Separation of Chairman and Chief Executive Officer Roles
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 30 Jan 2008
FDA Grants Priority Review For Velcade(R) (bortezomib) for Injection In Patients with Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Jan 2008
Alsius Corporation Launches Thermogard XP(TM) Intravascular Temperature Management System
Devices
 HSMN NewsFeed - 23 Jan 2008
NMT Medical Announces Significant Changes to Its Clinical Trial Plans in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jan 2008
Northstar Neuroscience Announces Primary Endpoint Results of EVEREST Clinical Trial
Devices Neurology
 HSMN NewsFeed - 17 Jan 2008
Micrus Endovascular and Genesis Medical Interventional Sign License, Development and Commercialization Agreement
Devices Interventional Neurology Licensing
 HSMN NewsFeed - 21 Dec 2007
Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 20 Dec 2007
GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2007
Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
Biopharmaceuticals Neurology Interventional
 HSMN NewsFeed - 10 Dec 2007
VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2007
Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2007
Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Dec 2007
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 28 Nov 2007
High Blood Pressure May Heighten Effects of Alzheimer's Disease
Radiology Neurology
 HSMN NewsFeed - 28 Nov 2007
Toshiba Unveils New Low-Contrast X-Ray Imaging Feature at RSNA
Devices Radiology
 HSMN NewsFeed - 26 Nov 2007
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Nov 2007
New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Nov 2007
Toshiba Announces Its Fourth Generation Contrast-Free Technique -- Time and Space Angiography (TSA)
Devices Radiology
 HSMN NewsFeed - 13 Nov 2007
Northstar Neuroscience Announces Updated Timeline for EVEREST Pivotal Trial Data Analysis and Planned PMA Submission
Devices Neurology
 HSMN NewsFeed - 12 Nov 2007
Actelion: Pivlaz (Clazosentan) Phase III Study Initiated to Demonstrate Prevention of Vasospasm-Related Morbidity and All-Cause Mortality After Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 9 Nov 2007
NMT Medical Wins Favorable Ruling in Patent Infringement Lawsuit Against Cardia
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 8 Nov 2007
Micrus Endovascular Names Gordon Sangster Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 5 Nov 2007
Merit Medical to Acquire Cardiac and Peripheral Assets From Micrus Endovascular
Devices Interventional Acquisitions
 HSMN NewsFeed - 5 Nov 2007
Micrus Endovascular to Divest $3 Million in Non-Core Cardiac and Peripheral Assets to Merit Medical Systems
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
Next Generation Devices to Treat Clogged Neck Arteries Launched in U.S. and Europe
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 19 Oct 2007
NMT Medical Appoints James J. Mahoney, Jr., to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Oct 2007
Northstar Neuroscience Announces Final Patient Completes Four Week Follow-up in EVEREST Pivotal Trial
Devices Neurology
 HSMN NewsFeed - 15 Oct 2007
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 10 Oct 2007
Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2007
Luna Innovations Signs Marketing Agreement with Terumo Cardiovascular Systems
Devices Cardiology
 HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals
 HSMN NewsFeed - 24 Sep 2007
Micrus Endovascular Board of Directors Names CEO John Kilcoyne Chairman and Promotes Robert Stern to President
Devices Personnel
 HSMN NewsFeed - 21 Sep 2007
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Sep 2007
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Sep 2007
Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Sep 2007
Carl Zeiss Meditec, Inc. Ships 1,000th OPMI(R) Pentero(R) Surgical Microscope to Loyola University Health System
Devices Neurosurgery
 HSMN NewsFeed - 13 Sep 2007
The Society of Thoracic Surgeons Adds Cerebral Oximetry as Metric to STS Adult Cardiac Surgery Database
Devices Monitoring Surgery
 HSMN NewsFeed - 11 Sep 2007
Integra LifeSciences Announces Launch of the Camino Advanced Monitor, a State of the Art Monitoring System for Traumatic Brain Injury Patients
Devices Monitoring Neurosurgery
 HSMN NewsFeed - 5 Sep 2007
Penumbra, Inc. Completes Pivotal Stroke Trial of Intracranial Revascularization
Devices Interventional Radiology Neurology
 HSMN NewsFeed - 28 Aug 2007
Neurochem provides information on cash position
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2007
Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Aug 2007
Micrus Endovascular Signs Distribution Agreement to Enter Chinese Market
Devices Interventional Neurology Distribution
 HSMN NewsFeed - 31 Jul 2007
Micrus Endovascular Signs Letter of Intent to Acquire Revascularization Technology to Treat Ischemic Stroke
Devices Interventional Neurology
 HSMN NewsFeed - 30 Jul 2007
ev3 Receives CE Mark Approval for the Axium(TM) Detachable Coil System
Devices Interventional Radiology Neurology FDA
 HSMN NewsFeed - 25 Jul 2007
NMT Medical Announces the Commercial Launch of BioSTAR(R) in Europe and Canada
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Jul 2007
CoAxia(TM) Announces First Use of NeuroFlo(TM) Technology in Study for Stroke Patients After Attempted Thrombolysis
Devices Neurology Interventional
 HSMN NewsFeed - 24 Jul 2007
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Devices Interventional Cardiology Regenerative Medicine
 HSMN NewsFeed - 17 Jul 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jul 2007
Hanger Orthopedic Group, Inc. Announces a Commercialization Agreement Between Its Subsidiary, Innovative Neurotronics, and Teijin Limited for the WalkAide System in the Japanese Market
Devices Licensing
 HSMN NewsFeed - 16 Jul 2007
Millennium Initiates Phase III Trial to Determine the Optimal VELCADE(R) (Bortezomib) for Injection Based Therapy in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jul 2007
NMT Medical Appoints David L. West, Ph.D., MPH to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 2 Jul 2007
VELCADE(R) (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
NMT Medical Receives CE Mark Approval for BioSTAR(R)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Jun 2007
Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2007
Neurochem receives third recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 18 Jun 2007
NMT Medical's BioSTAR(R) Receives Canadian Regulatory Approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Jun 2007
NeuroVasx, Inc. Announces 510(k) FDA Submission of its cPAX Aneurysm Treatment System(TM) for Treatment of Cerebral Aneurysms
Devices Interventional Neurology
 HSMN NewsFeed - 13 Jun 2007
Toshiba Introduces SURESubtraction Software Package for Neurological CT Angiography Procedures
Devices Radiology Neurology
 HSMN NewsFeed - 7 Jun 2007
Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA(TM)) Treatment for Patients with Amyloid A (AA) Amyloidosis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2007
NMT Medical Wins Favorable Ruling in Patent Infringement Lawsuit Against Cardia
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 4 Jun 2007
New Data on Market-Leading VELCADE(R) (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapy Substantially Improves Event-Free Survival and Complete Response Rate in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
VELCADE(R) (bortezomib) for Injection Based Therapies Produced High Complete Response Rates in Newly Diagnosed Non-Hodgkin's Lymphoma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2007
First Patient Enrolled in SONOMA Post-Market Approval Study of Boston Scientific NexStent(R) Carotid Stent System and FilterWire EZ(TM) Embolic Protection Device
Devices Interventional
 HSMN NewsFeed - 31 May 2007
Northstar Neuroscience Announces the Completion of Subject Enrollment and Randomization in the EVEREST Pivotal Trial for Upper Extremity Motor Recovery in Stroke Survivors
Devices Neurology
 HSMN NewsFeed - 30 May 2007
FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 May 2007
CoAxia(TM) Announces First Patients Enrolled in Study Extending Treatment for Acute Stroke Up to 24 Hours
Devices Neurology Interventional
 HSMN NewsFeed - 29 May 2007
Micrus Endovascular Receives FDA Clearance for the ENZO Steerable Microcatheter
Devices Neurology Interventional FDA
 HSMN NewsFeed - 21 May 2007
Luna Innovations Blood Circuit Monitor Receives FDA Clearance
Devices Surgery Cardiology FDA
 HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 May 2007
New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms
Devices FDA Neurology Interventional
 HSMN NewsFeed - 8 May 2007
Analogic Corporation and CAS Medical Systems Inc. Announce Agreement to Co-brand Analogic's LIFEGARD Family of Non-invasive Patient Monitors
Devices Monitoring
 HSMN NewsFeed - 4 May 2007
Micrus Endovascular Launches Cashmere Microcoil System to Treat Complex Cerebral Aneurysms
Devices Neurology Interventional
 HSMN NewsFeed - 1 May 2007
CleveMed Receives FDA Clearance to Market Wireless Movement Disorder Monitor
Devices Neurology Monitoring
 HSMN NewsFeed - 30 Apr 2007
Northstar Neuroscience Announces Initial Feasibility Data on the Use of its Renova(TM) Cortical Stimulation System to Treat Tinnitus
Devices Neurology
 HSMN NewsFeed - 27 Apr 2007
Hemedex Signs Distribution Agreement with Codman
Devices Monitoring Neurosurgery Distribution
 HSMN NewsFeed - 26 Apr 2007
Northstar Neuroscience Announces Management and Board Succession Plan
Devices Neurology Personnel
 HSMN NewsFeed - 26 Apr 2007
Study Supports Cost-Effectiveness of Medtronic's Spasticity Treatment for Children with Cerebral Palsy
Devices Neurology
 HSMN NewsFeed - 26 Apr 2007
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Apr 2007
NMT Medical Receives FDA Approval for Modifications in Pivotal U.S. PFO/Stroke Trial
Devices FDA Interventional Cardiology Neurology
 HSMN NewsFeed - 20 Apr 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2007
ev3's Onyx HD 500 Receives HDE Approval from FDA for Treatment of Cerebral Aneurysms
Devices Interventional Neurology FDA
 HSMN NewsFeed - 16 Apr 2007
Integra LifeSciences Announces New Proposed Tracking Codes for Intracranial Monitoring
Devices Monitoring Reimbursement Neurosurgery
 HSMN NewsFeed - 12 Apr 2007
Positive Results Prompt US National Cancer Institute to Make Gleevec(R) Available To Patients in Post-Surgical GIST Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Apr 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Apr 2007
Final Patient Enrolled In International Trial of MicroVention's HydroCoil(R) Embolic System
Devices Interventional
 HSMN NewsFeed - 22 Mar 2007
North American Scientific Names John Rush to Serve as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology
 HSMN NewsFeed - 23 Feb 2007
Swedish Medical Center Enhances Neuroscience Institute With Portable CT Scanner from NeuroLogica
Devices Radiology Neuro
 HSMN NewsFeed - 20 Feb 2007
CereTom(TM) Mobile Brain CT Imaging Machine Enabling More Access and Faster Scans at Thomas Jefferson University Hospital
Devices Radiology Neuro
 HSMN NewsFeed - 15 Feb 2007
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration
Devices Interventional FDA
 HSMN NewsFeed - 13 Feb 2007
Neurochem receives second recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices
 HSMN NewsFeed - 1 Feb 2007
Neurochem announcement regarding the completion of its North American phase III clinical trial for tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Jan 2007
Indianapolis' Methodist Hospital Installs Portable CT Scanner from NeuroLogica
Devices Radiology Neurology
 HSMN NewsFeed - 22 Jan 2007
Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jan 2007
CAS Medical Systems, Inc. Appoints Andrew Kersey President and CEO
Devices Monitoring Personnel
 HSMN NewsFeed - 12 Jan 2007
Catalyst Pharmaceutical Partners, Inc. Adds Thomas Kosten, M.D. to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2007
Medistem Laboratories Appoints Thomas Ichim to Be Chief of Scientific Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 3 Jan 2007
Cleveland Clinic Sees Neuroimaging Important to Faster ER Diagnosis of Stroke and Brain Trauma
Devices Radiology Neurology
 HSMN NewsFeed - 3 Jan 2007
Northstar Neuroscience Awarded U.S. Patent for Cortical Stimulation Therapy
Devices Neurology
 HSMN NewsFeed - 21 Dec 2006
Natus Medical Receives FDA Approval for the Olympic Cool-Cap
Devices FDA Neurology
 HSMN NewsFeed - 20 Dec 2006
Gore Announces First Use of GORE Embolic Liquid to Occlude Cerebral Arteriovenous Malformation at Oregon Health & Science University
Devices Neurosurgery Interventional
 HSMN NewsFeed - 14 Dec 2006
Dr. Bob Tepper, President of R&D, to Leave Millennium
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2006
CoAxia(TM) Announces FDA Approval of Clinical Trial for Its Novel Stroke Treatment in Patients up to 24 Hours After Onset
Devices Neurology Interventional FDA
 HSMN NewsFeed - 13 Dec 2006
CAS Medical Systems, Inc. Launches FORE-SIGHT(TM) Cerebral Oximeter at the PostGraduate Assembly for Anesthesiology
Devices Monitoring
 HSMN NewsFeed - 12 Dec 2006
VELCADE(R) (bortezomib) for Injection Incorporated Into NCCN(R) Clinical Practice Guidelines for Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
VELCADE(R) (Bortezomib) for Injection Demonstrates Substantial Activity Across Range of Lymphomas
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Positive Results from Combination Trials Build on VELCADE(R) (Bortezomib) for Injection Proven Single-Agent Strength in Relapsed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Multiple Myeloma Patients Respond to Retreatment with VELCADE(R) (Bortezomib) for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No Longer Helped by Gleevec(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2006
VELCADE(R) (Bortezomib) for Injection Combination Shows High Complete and Near Complete Response Rate in Preliminary Data From Phase III Front-Line Multiple Myeloma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2006
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Dec 2006
Micrus Endovascular Acquires Catheter Technology Company VasCon LLC
Devices Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2006
Micrus Endovascular Announces Positive Results from Prospective Cerecyte Study
Devices Neurology Interventional
 HSMN NewsFeed - 8 Nov 2006
Stroke Survivors Benefit Significantly from Targeted Spasticity Treatment Using Medtronic Drug Pump, Study Finds
Devices Neurology Drug Delivery
 HSMN NewsFeed - 6 Nov 2006
Neurochem receives recommendations from data safety monitoring boards to continue phase III clinical trials for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Nov 2006
Tramiprosate (ALZHEMED(TM)) Phase II Clinical Results Published in Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Nov 2006
Innovative Neurotronics Receives CE Mark Approval for the WalkAide System
Devices Orthopaedic Neurology Regulatory
 HSMN NewsFeed - 1 Nov 2006
MRI Analysis Could Prevent Brain Damage From Stroke, Stanford Study Finds
Devices Radiology Neurology
 HSMN NewsFeed - 24 Oct 2006
NMT Medical's BioSTAR(R) Data Presented at 2006 TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Stem Cell Treatment Proven to Reduce Parkinson's Symptoms
Regenerative Medicine Neurology
 HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2006
Natus Medical to Acquire Olympic Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2006
Elekta Wins Tender to Deliver Sophisticated 3-D Brain Mapping Technology to Leading German Institution
Devices Neurology
 HSMN NewsFeed - 9 Oct 2006
Actelion Ltd: Detailed Analysis of CONSCIOUS-1 Presented at CNS
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 9 Oct 2006
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 4 Oct 2006
Schering AG and Biogen Idec Announce Start of the ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Oct 2006
NMT Medical's BioSTAR(R) Data to be Presented at the 2006 TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Sep 2006
U.S. Food and Drug Administration Approves New Medical Devices to Treat Clogged Neck Arteries
Devices Interventional FDA
Return to NewsFeed  

 Additional items found! 282

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 282 additional stories matching:
cerebral
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.